Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-13 @ 9:45 AM
Study NCT ID:
NCT00737659
Status:
UNKNOWN
Last Update Posted:
2010-03-26
First Post:
2008-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients
Sponsor:
Rabin Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ML21706
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Eytan Mor Prof.
Old Organization:
Rabin MC